Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

22 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Long-term treatment-free remission in patients with chronic myeloid leukemia after second-line nilotinib: ENESTop 5-year update.
Hughes TP, Clementino NCD, Fominykh M, Lipton JH, Turkina AG, Moiraghi EB, Nicolini FE, Takahashi N, Sacha T, Kim DW, Fellague-Chebra R, Tiwari R, Bouard C, Mahon FX. Hughes TP, et al. Among authors: clementino ncd. Leukemia. 2021 Jun;35(6):1631-1642. doi: 10.1038/s41375-021-01260-y. Epub 2021 May 12. Leukemia. 2021. PMID: 33980976
Lower socioeconomic status is independently associated with shorter survival in Hodgkin Lymphoma patients-An analysis from the Brazilian Hodgkin Lymphoma Registry.
Biasoli I, Castro N, Delamain M, Silveira T, Farley J, Pinto Simões B, Solza C, Praxedes M, Baiocchi O, Gaiolla R, Franceschi F, Bonamin Sola C, Boquimpani C, Clementino N, Fleury Perini G, Pagnano K, Steffenello G, Tabacof J, de Freitas Colli G, Soares A, de Souza C, Chiattone CS, Raggio Luiz R, Milito C, Morais JC, Spector N. Biasoli I, et al. Int J Cancer. 2018 Mar 1;142(5):883-890. doi: 10.1002/ijc.31096. Epub 2017 Oct 26. Int J Cancer. 2018. PMID: 29023692
Treatment-Free Remission After Second-Line Nilotinib Treatment in Patients With Chronic Myeloid Leukemia in Chronic Phase: Results From a Single-Group, Phase 2, Open-Label Study.
Mahon FX, Boquimpani C, Kim DW, Benyamini N, Clementino NCD, Shuvaev V, Ailawadhi S, Lipton JH, Turkina AG, De Paz R, Moiraghi B, Nicolini FE, Dengler J, Sacha T, Takahashi N, Fellague-Chebra R, Acharya S, Wong S, Jin Y, Hughes TP. Mahon FX, et al. Among authors: clementino ncd. Ann Intern Med. 2018 Apr 3;168(7):461-470. doi: 10.7326/M17-1094. Epub 2018 Feb 20. Ann Intern Med. 2018. PMID: 29459949 Clinical Trial.
Treatment outcomes for Hodgkin lymphoma: First report from the Brazilian Prospective Registry.
Biasoli I, Castro N, Delamain M, Silveira T, Farley J, Simões BP, Solza C, Praxedes M, Baiocchi O, Gaiolla R, Franceschi F, Sola CB, Boquimpani C, Clementino N, Perini G, Pagnano K, Steffenello G, Tabacof J, de Freitas Colli G, Soares A, de Souza C, Chiattone CS, Milito C, Morais JC, Spector N. Biasoli I, et al. Hematol Oncol. 2018 Feb;36(1):189-195. doi: 10.1002/hon.2450. Epub 2017 Jun 23. Hematol Oncol. 2018. PMID: 28643458
BCR-ABL mutations in chronic myeloid leukemia treated with tyrosine kinase inhibitors and impact on survival.
Pagnano KB, Bendit I, Boquimpani C, De Souza CA, Miranda EC, Zalcberg I, Larripa I, Nardinelli L, Silveira RA, Fogliatto L, Spector N, Funke V, Pasquini R, Hungria V, Chiattone CS, Clementino N, Conchon M, Moiraghi EB, Lopez JL, Pavlovsky C, Pavlovsky MA, Cervera EE, Meillon LA, Simões B, Hamerschlak N, Bozzano AH, Mayta E, Cortes J, Bengió RM; Latin American Leukemia Net (LALNET). Pagnano KB, et al. Cancer Invest. 2015;33(9):451-8. doi: 10.3109/07357907.2015.1065499. Epub 2015 Aug 17. Cancer Invest. 2015. PMID: 26288116
Chronic lymphocytic leukemia in Brazil: A retrospective analysis of 1903 cases.
Gonçalves MV, Rodrigues CA, Lorand Metze IGH, Lacerda MP, de Lourdes Lopes Ferrari Chauffaille M, Azevedo A, Machado C, Chiattone CS, Fortier S, Perobelli L, Ikoma MRV, Clementino N, Hamerschlak N, Sthel VM, Ommati LVM, de Farias DLC, Duarte FB, Buccheri V, de Azambuja AP, de Almeida DR, Figueiredo VLP, Yamamoto M. Gonçalves MV, et al. Am J Hematol. 2017 Aug;92(8):E171-E173. doi: 10.1002/ajh.24779. Epub 2017 Jun 9. Am J Hematol. 2017. PMID: 28474845 Free article. No abstract available.
Deep molecular responses achieved in patients with CML-CP who are switched to nilotinib after long-term imatinib.
Hughes TP, Lipton JH, Spector N, Cervantes F, Pasquini R, Clementino NC, Dorlhiac Llacer PE, Schwarer AP, Mahon FX, Rea D, Branford S, Purkayastha D, Collins L, Szczudlo T, Leber B. Hughes TP, et al. Among authors: clementino nc. Blood. 2014 Jul 31;124(5):729-36. doi: 10.1182/blood-2013-12-544015. Epub 2014 Jun 19. Blood. 2014. PMID: 24948656 Free article. Clinical Trial.
22 results